SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-002093
Filing Date
2021-03-26
Accepted
2021-03-26 08:00:10
Documents
12
Period of Report
2021-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_032521.htm   iXBRL 8-K 23529
  Complete submission text file 0001171843-21-002093.txt   198954

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE kron-20210325.xsd EX-101.SCH 2732
3 XBRL LABEL FILE kron-20210325_lab.xml EX-101.LAB 34591
4 XBRL PRESENTATION FILE kron-20210325_pre.xml EX-101.PRE 22694
5 EXTRACTED XBRL INSTANCE DOCUMENT f8k_032521_htm.xml XML 3827
Mailing Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 21774745
SIC: 2834 Pharmaceutical Preparations